Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

DGAP-News: ADO Properties S.A.: Disposal of 5,000 residential assets above book value
DGAP-News: ADO Properties S.A.: Disposal of 5,000 residential assets above book value
DGAP-News: ADO Properties S.A.: Disposal of 5,000 residential assets above book value
eqs_en 
0 18.09.20
DGAP-News: VIB Vermögen expands portfolio with further in-house developments
DGAP-News: VIB Vermögen expands portfolio with further in-house developments
DGAP-News: VIB Vermögen expands portfolio with further in-house developments
eqs_en 
0 18.09.20
DGAP-News: Nordex SE: The Nordex Group wins order in the USA for 312 MW: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24063/Nordex_Logo.svg.png
DGAP-News: Nordex SE: The Nordex Group wins order in the USA for 312 MW
DGAP-News: Nordex SE: The Nordex Group wins order in the USA for 312 MW
eqs_en 
0 18.09.20
DGAP-News: SFC Energy cooperates with ePropulsion in the field of electric boat drives - EFOY fuel cell provides power for the test winner outboard motor Spirit 1.0 PLUS
DGAP-News: SFC Energy cooperates with ePropulsion in the field of electric boat drives - EFOY fuel cell provides power for the test winner outboard motor Spirit 1.0 PLUS
DGAP-News: SFC Energy cooperates with ePropulsion in the field of electric boat drives - EFOY fuel cell provides power for the test winner outboard motor Spirit 1.0 PLUS
eqs_en 
0 18.09.20
DGAP-News: ADLER Real Estate AG: ADLER agrees disposal of 5,000 residential assets above book value: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24087/Adler_Real_Estate_logo.svg.png
DGAP-News: ADLER Real Estate AG: ADLER agrees disposal of 5,000 residential assets above book value
DGAP-News: ADLER Real Estate AG: ADLER agrees disposal of 5,000 residential assets above book value
eqs_en 
0 18.09.20
EQS-Adhoc: AEVIS VICTORIA SA: Half-year results 2020 - Good overall resilience to COVID-19 crisishttp://www.aevis.com: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/12720/aevis-logo.png
EQS-Adhoc: AEVIS VICTORIA SA: Half-year results 2020 - Good overall resilience to COVID-19 crisis
EQS-Adhoc: AEVIS VICTORIA SA: Half-year results 2020 - Good overall resilience to COVID-19 crisis
eqs_en 
0 18.09.20
DGAP-News: DEMIRE Deutsche Mittelstand Real Estate AG: DEMIRE is letting around 4,600sqm in Düsseldorf office complex
DGAP-News: DEMIRE Deutsche Mittelstand Real Estate AG: DEMIRE is letting around 4,600sqm in Düsseldorf office complex
DGAP-News: DEMIRE Deutsche Mittelstand Real Estate AG: DEMIRE is letting around 4,600sqm in Düsseldorf office complex
eqs_en 
0 18.09.20
DGAP-News: Corestate acquires Trophy city quarter in Nuremberg from Gerchgroup for Bayerische Versorgungskammer
DGAP-News: Corestate acquires Trophy city quarter in Nuremberg from Gerchgroup for Bayerische Versorgungskammer
DGAP-News: Corestate acquires Trophy city quarter in Nuremberg from Gerchgroup for Bayerische Versorgungskammer
eqs_en 
0 18.09.20
DGAP-News: MorphoSys and Incyte to Host Investor Event to Discuss the Unmet Need and Global Opportunities for Tafasitamab in Non-Hodgkin Lymphomas: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
DGAP-News: MorphoSys and Incyte to Host Investor Event to Discuss the Unmet Need and Global Opportunities for Tafasitamab in Non-Hodgkin Lymphomas
DGAP-News: MorphoSys and Incyte to Host Investor Event to Discuss the Unmet Need and Global Opportunities for Tafasitamab in Non-Hodgkin Lymphomas
eqs_en 
0 17.09.20
DGAP-News: MorphoSys and I-Mab Announce FDA Clearance of IND Application for MOR210/TJ210 in Patients with Advanced Cancer: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24061/Morphosys-logo.svg.png
DGAP-News: MorphoSys and I-Mab Announce FDA Clearance of IND Application for MOR210/TJ210 in Patients with Advanced Cancer
DGAP-News: MorphoSys and I-Mab Announce FDA Clearance of IND Application for MOR210/TJ210 in Patients with Advanced Cancer
eqs_en 
0 17.09.20
DGAP-Adhoc: MAN SE: TRATON SE is not seeking the execution of the merger squeeze-out of the minority shareholders of MAN SE in 2020
DGAP-Adhoc: MAN SE: TRATON SE is not seeking the execution of the merger squeeze-out of the minority shareholders of MAN SE in 2020
DGAP-Adhoc: MAN SE: TRATON SE is not seeking the execution of the merger squeeze-out of the minority shareholders of MAN SE in 2020
eqs_en 
0 17.09.20
DGAP-Adhoc: TRATON SE: TRATON SE is not seeking the execution of the merger squeeze-out of the minority shareholders of MAN SE in 2020
DGAP-Adhoc: TRATON SE: TRATON SE is not seeking the execution of the merger squeeze-out of the minority shareholders of MAN SE in 2020
DGAP-Adhoc: TRATON SE: TRATON SE is not seeking the execution of the merger squeeze-out of the minority shareholders of MAN SE in 2020
eqs_en 
0 17.09.20
EQS-Adhoc: Further strengthening of organization: SVP Consumptional Business New Member of ALSO Group Management
EQS-Adhoc: Further strengthening of organization: SVP Consumptional Business New Member of ALSO Group Management
EQS-Adhoc: Further strengthening of organization: SVP Consumptional Business New Member of ALSO Group Management
eqs_en 
0 17.09.20
RUBIS: Great resilience in the face of Covid - EBITDA: down 11% - Net income: down 11%
RUBIS: Great resilience in the face of Covid - EBITDA: down 11% - Net income: down 11%
RUBIS: Great resilience in the face of Covid - EBITDA: down 11% - Net income: down 11%
eqs_en 
0 17.09.20
RUBIS: Availability of the 2020 half-year financial report
RUBIS: Availability of the 2020 half-year financial report
RUBIS: Availability of the 2020 half-year financial report
eqs_en 
0 17.09.20
DGAP-News: GRENKE AG: Wolfgang Grenke comments on the franchise system of GRENKE AG: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24105/Grenke_Logo.jpg
DGAP-News: GRENKE AG: Wolfgang Grenke comments on the franchise system of GRENKE AG
DGAP-News: GRENKE AG: Wolfgang Grenke comments on the franchise system of GRENKE AG
eqs_en 
0 17.09.20
DGAP-Adhoc: Mutares SE & Co. KGaA resolves on share buyback program with a volume of up to EUR 2.5 million
DGAP-Adhoc: Mutares SE & Co. KGaA resolves on share buyback program with a volume of up to EUR 2.5 million
DGAP-Adhoc: Mutares SE & Co. KGaA resolves on share buyback program with a volume of up to EUR 2.5 million
eqs_en 
0 17.09.20
Form 8.3 - The Vanguard Group, Inc.: G4S plc
Form 8.3 - The Vanguard Group, Inc.: G4S plc
Form 8.3 - The Vanguard Group, Inc.: G4S plc
eqs_en 
0 17.09.20
Hardman & Co Research: City of London Investment Group (CLIG): Solid results, with surprise dividend increase
Hardman & Co Research: City of London Investment Group (CLIG): Solid results, with surprise dividend increase
Hardman & Co Research: City of London Investment Group (CLIG): Solid results, with surprise dividend increase
eqs_en 
0 17.09.20
Form 8.3 - The Vanguard Group, Inc.: Willis Towers Watson plc
Form 8.3 - The Vanguard Group, Inc.: Willis Towers Watson plc
Form 8.3 - The Vanguard Group, Inc.: Willis Towers Watson plc
eqs_en 
0 17.09.20
Form 8.3 - The Vanguard Group, Inc.: Aon plc
Form 8.3 - The Vanguard Group, Inc.: Aon plc
Form 8.3 - The Vanguard Group, Inc.: Aon plc
eqs_en 
0 17.09.20
Form 8.3 - SDL Plc
Form 8.3 - SDL Plc
Form 8.3 - SDL Plc
eqs_en 
0 17.09.20
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
Chelverton UK Dividend Trust plc: Net Asset Value(s)
eqs_en 
0 17.09.20
Fuller, Smith & Turner PLC: PDMR Shareholding
Fuller, Smith & Turner PLC: PDMR Shareholding
Fuller, Smith & Turner PLC: PDMR Shareholding
eqs_en 
0 17.09.20
DGAP-News: Dyadic International, Inc.: Dyadic Announces Collaboration with Jiangsu Hengrui Medicine for Biologic Drug Development
DGAP-News: Dyadic International, Inc.: Dyadic Announces Collaboration with Jiangsu Hengrui Medicine for Biologic Drug Development
DGAP-News: Dyadic International, Inc.: Dyadic Announces Collaboration with Jiangsu Hengrui Medicine for Biologic Drug Development
eqs_en 
0 17.09.20